Medscape Education is a proud sponsor of the 2025 SDNP National Conference, taking place from April 30 to May 3 at the ...

AI is revolutionising the pharmaceutical industry, as highlighted at Reuters Pharma 2025, with transformative applications ...

The answer is yes, pharma can have an impact We can and should use our expertise and resources to tackle misinformation.

Generics account for 81% of U.K. primary care prescriptions but just 28% of NHS medicines spending, delivering significant ...

The phase 3 CREST trial has been assessing the subcutaneously-administered drug in combination with standard-of-care Bacillus ...

Roche has become the latest major drugmaker to announce a significant investment in the US, committing $50bn into the country ...

Merck KGaA has announced that it will be acquiring SpringWorks Therapeutics for approximately $3.9bn. The definitive ...

Now more than ever we need to remain focused on the real goals of DE&I – and whether we call it that or not, we surely must ...

Boehringer Ingelheim and Tessellate Bio have entered into a partnership worth over €500m to develop oral precision medicines ...

But the legal and regulatory framework is evolving to keep pace. The EU AI Act, GDPR and medical device regulations are ...

Gilead Sciences has shared positive top-line results from a late-stage study evaluating its antibody-drug conjugate (ADC) ...

Biogen’s Skyclarys (omaveloxolone) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as the ...